According to In the Pipeline - when it's Pfizer. And likely most other Big Pharma companies too. As posted here yesterday, Pfizer intends to cut back to its "innovative core" by spinning off it non-Pharma divisions. This will allow it to concentrate on the drug business. Now -- can Pfizer be successful doing that?
It seems most analysts and pundits woudl like to see them give it a shot -- as what they have been doing is thrilling no one.
Posted by Bruce Lehr March 15th 2011.
Comments